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Abstract
Background: There is growing interest in the use of plants for the treatment and prevention of cancer. Medicinal
plants are currently being evaluated as source of promising anticancer agents. In this paper, we have investigated
the anticancer potential of plant Allium wallichii, a plant native to Nepal and growing at elevations of 2300–4800 m.
This is the first study of its kind for the plant mentioned.
Methods: The dried plant was extracted in aqueous ethanol. Phytochemical screening, anti-microbial assay,
anti-oxidant assay, cytotoxicity assay and the flow-cytometric analysis were done for analyzing different
phytochemicals present, anti-microbial activity, anti-oxidant activity and anti-cancer properties of Allium wallichii.
Results: We observed the presence of steroids, terpenoids, flavonoids, reducing sugars and glycosides in the plant
extract and the plant showed moderate anti-microbial and anti-oxidant activity. The IC50 values of Allium wallichii in
different cancer cell lines are 69.69 μg/ml for Prostate cancer (PC3) cell line, 55.29 μg/ml for Breast Cancer (MCF-7)
cell line and 46.51 μg/ml for cervical cancer (HeLa) cell line as compared to Doxorubicin (0.85 μg/ml). The cell
viability assay using FACS showed that the IC50value of Allium wallichii for Burkitt’s lymphoma (B-Lymphoma) cell
line was 3.817 ± 1.99 mg/ml.
Conclusions: Allium wallichii can be an important candidate to be used as an anticancer agent. Separation of pure
compounds with bioassay guided extraction, spectrometric analysis and subsequent cytotoxicity assay of the
pure bioactive compounds from Allium wallichii is highly recommended as the crude extract itself showed
promising cytotoxicity.
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Background
Medicinal plants are considered as potential source for
drug development and many novel products have
reached clinical trials. Scientists are investigating proper-
ties of medicinal plants in order to develop novel drugs
against disease like cancer, from natural products. Medi-
cinal herbs have profound scope and have been used to
find potential anticancer compounds in them [1]. Use of
phytochemicals from the medicinal plants in cancer
treatment, may reduce adverse side effects and help to
treat cancer and they have in recent years, shown prom-
ising anticancer efficiency against different cancers like
human mouth epidermal carcinoma (KB cell line),
murine leukemia (P388 cell line), human colorectal
cancer (BE cell line) and prostate cancer (PC3 cell line)
by various mechanisms like up-regulation of p16INK4A,
preventing inhibition of MRCK-kinase targeting multiple
gene products and targeting mitotic processes [2–8].
Many medicinal plants found in Nepal are also found to
have cytotoxic effects against different cancer cell lines.
For example, Cell viability assay of plant extracts from
Berberis aristata; showed a significant cytotoxicity to
MDA-MB-231 and U-87 MG human cancer cell line;
Withanone from Withania somnifera (Ashwagandha)
has been identified to have p53-activating tumor-
inhibiting property. Ashwagandha leaf powder was
non-toxic and anti-tumorigenic in mice assays and
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caused an abrogation of mortalin-p53 interactions and
reactivation of p53 function and it is also established
that the different extracts of plant Juniperus recurva
possess anticancer properties against Breast Cancer
(MCF7) cells [9–12].
Allium wallichii(AW)
Allium wallichii is a monocotyledonous plant falling in
order Asparagales, family Amaryllidaceae and Allioideae
subfamily. It has been used as traditional medicine and
spice in Nepal. Recent research papers deal with the
genetic diversity and relationship of two species of
Allium by amplified fragment length polymorphism
analysis [13]. The phylogenetic and biogeographic in-
vestigation of Allium sp. based on nuclear ribosomal in-
ternal transcribed spacer and chloroplast ribosomal
protein S16 (rps16) sequences implied that genus Allium
comprises more than 800 species, which defends its
place among the largest genera in monocotyledons [14].
Use of plant resource and traditional medicine in Nepal
has also been documented for millennia and they are
still the most significant health care source for bulk of
population [15]. There have been reports of trnK-gene-
based molecular phylogenetic studies of plants of genus
Allium [16]. 1, 2 bis (methylthio) ethene, 2, 4 di-
Methiophene, di-Methyl disulfide and di-Methyl trisulfide
were established to be the most important volatile constitu-
ents of Allium wallichii [17]. Diosgenin and Tigogenin are
reported as steroidal sapogenins from bulbs of Allium
wallichii. Kunth, that shows encouraging pharmacological
potentials [18]. Neuropsychopharmacological utilization
has also been conferred in the studies of the action of
Allium sp. which shed light to its diverse use [19]. Extracts
that includes Allium sp. is found to exhibit analgesic and
fever relieving effects and can be used for the treatment of
inflammation, ulcer, viral infection, cancer, eczema, dia-
betes, senile gangrene, herpes zoster and most importantly
Acquired Immune Deficiency Syndrome (AIDS) [20].
In this paper we have investigated the presence of
different phytochemicals in Allium wallichii and also
established the anti -microbial, anti-oxidant activity of
the crude extract of the plant. More importantly this
paper is focused in establishing the anticancer potential
of the extracts of Allium wallichii by in-vitro cytotoxicity
assay against Prostrate, Cervical and Breast cancer cell
lines and Flow-cytometric analysis for viability assay
against B-lymphoma cell lines. This is the first study of
its kind for the plant Allium wallichii.
Methods
Collection of plant material
Allium wallichii (AW) whole plants were collected from
Kathmandu University campus area of Kavrepalanchowk
district, Nepal. The plant material was identified by
Dr. Rajendra Gyawali, Botanist, Assistant Professor of
Department of Pharmacy, Kathmandu University, Nepal.
A voucher herbarium specimen is deposited at the
herbarium of the Department of Pharmacy, Kathmandu
University, Nepal and the voucher specimen number is
DoP-H-211. The plant samples were then dried in shade,
left over for 15 days and macerated and powdered with
the help of kitchen grinder.
Preparation of plant extract
The dry powder of Allium wallichii (100 g) was dipped
in 80% Aq. Ethanol for three days stirring twice a day.
The solution at the end of third day was filtered and
then concentrated in high vacuum-rotary evaporator and
finally all the solvent was evaporated using freeze dryer
to get the semi-solid plant extract. The same procedure
was repeated three times and the freeze-dried extract
was mixed together. The extract was then kept in glass
vial with airtight caps and stored at 4 °C.
Phytochemical screening
The phytochemical screening was done using the stand-
ard protocols [21–28]. Test for Alkaloids: 5 ml of extract
was concentrated to yield a residue. Residue was dis-
solved in 3ml of 2% (v/v) HCl, few drops of Mayer’s
reagent was added. Appearance of the dull white precipi-
tate indicated the presence of basic alkaloids. Test for
Coumarin: 4 ml extract solution was taken; 1–2 drops of
water (hot) was added. Volume was made half (UV
fluorescence). 10% NH4OH was added to another half
volume (strong fluorescence). Presence of green fluores-
cence indicated the presence of Coumarin. Test for
Saponins: 2 ml extract was shaken vigorously for 30 s in
a test tube. Persistence of thick forth even after 30 mins
indicated the presence of saponins. Test for Glycosides:
2 ml of extract was dried till 1 ml.1-2 ml NH4OH was
added and shaken. Appearance of cherish red color indi-
cated the presence of glycosides. Test for Reducing
Sugars: 0.5 ml of extract was taken and 1ml distilled
water was added. 5-8 drops of Fehling’s solution (hot)
was added. Presence of brick red precipitation indicated
the presence of reducing sugar. Test for steroids: 1 ml
extract was dissolved in 10 ml chloroform. Equal volume
of conc. H2SO4 was added by the side of test tube.
Upper layer turned red and sulphuric acid layer turned
yellow with green fluorescence. This indicated the
presence of steroids. Test for Quinone: 1 ml of extract
was taken.1 ml of conc. H2SO4 was added. Formation of
red color indicated the presence of quinone. Test for
Terpenoids: 5 ml of extract was taken and mixed with
2 ml of chloroform. 3 ml of conc. H2SO4 was added to
form a layer. Reddish brown precipitate formation at the
interface formed indicated the presence of terpenoids.
Test for Tannins: About 0.5 g of the dried powdered
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samples was boiled in 20 ml of water in a test tube and
then filtered. Few drops of 0.1% Ferric Chloride was
added and observed for brownish green or a blue-black
coloration. Test for Flavonoids: A portion of the
powdered plant sample was heated with 10 ml of Ethyl
Acetate over a steam bath for 3 min. The mixture was
filtered and 4 ml of the filtrate was shaken with 1 ml of
dilute Ammonia solution. A yellow coloration was
observed indicating a positive test for flavonoids.
DPPH free radical scavenging assay
DPPH (2, 2-diphenyl-1-picrylhydrazyl radical), is a
dark-colored crystalline powder composed of stable
free-radical molecules. DPPH has major application in
laboratory research most notably in anti-oxidant assays.
The DPPH assay is typically run by the following stand-
ard procedure [29–31]. The hydrogen atom or electron
donating abilities of the corresponding extracts/frac-
tions and standards were measured from the bleaching
of the purple-colored methanol solution of DPPH.
10 mg DPPH was dissolved in 100 ml methanol
(MeOH) to obtain a concentration of 100 μg/ml. The
stock solution of the fractions/extracts was prepared by
dissolving 25 mg in 50 ml MeOH. Dilutions of the
stock solutions of the crude extracts were prepared to
obtain concentration of 1 μg/ml, 2 μg/ml, 3 μg/ml,
4 μg/ml, 5 μg/ml and 10 μg/ml while the control was
prepared by dissolving 1 ml DPPH in 4 ml MeOH
(without sample). 1 ml DPPH was added to each solu-
tion and the solution were kept in dark and allowed to
stand for exact 30 mins. The UV absorption of each
solution was recorded at 517 nm. The reaction was
allowed to progress for 30 mins at 37 °C and absorb-
ance was monitored by microplate reader, Spectra-
Max340 at 517 nm. Upon reduction, the color of the
solution fades (violet to pale yellow). Percent Radical
Scavenging Activity (% RSA) was determined by com-
parison with a DMSO containing control. The concen-
tration that causes a decrease in the initial DPPH
concentration by 50% is defined as IC50 value. Scaven-
ging of free radicals by DPPH as percent radical scaven-
ging activities was calculated as follows. % RSA =
Control absorbance – extract absorbance X 100/control
absorbance. The IC50 values of compounds were calcu-
lated by using the EZ-Fit Enzyme kinetics software pro-
gram (Perrella Scientific Inc. Amherst, MA, USA).
Ascorbic acid was used as the reference compound.
Agar plate diffusion method for anti-microbial activity
Medium was dissolved and autoclaved at 121 °C for
15 min, cooled up to 45 °C and then 40-50 ml media
was poured in sterile 14 cm diameter Petri plate, and
then allowed to solidify and kept at room temperature as
stated in the protocols [32–34].
Preparation of plant extract
Stock solution of 400 mg/ml was prepared by weighing
200 mg of plant extract in 1.5 ml Eppendorf tube and
0.5 ml of DMSO was added by micropipette. Extract was
completely dissolved by vortexing for 5–10 min. Test
solution of 200 mg/ml, 100 mg/ml, 50 mg/ml and
25 mg/ml concentrations was prepared.
Preparation of inoculums
Each culture to be tested was streaked onto nutrient
agar plate to obtain isolated colonies. Overnight incuba-
tion was done at 37 °C. Then isolated colonies were
transferred by the help of sterile loop onto Muller
Hinton Broth. Overnight incubation was done at rotary
shaker at 37 °C.
Inoculation
For inoculation, swabbing was done with the help of
cotton. Sterilized filter paper discs were dipped into the
desirable concentration of the plant extracts and then
applied to the plates; incubated at 37 °C for 24 h. After
incubation, the diameter of the Zone of inhibition was
measured.
MTT/cytotoxicity assay against cancer cell lines
Cytotoxic activity of plant extract was evaluated in
96-well flat-bottomed micro-titer plates by using the
standard MTT (3-[4, 5-dimethylthiazole-2-yl]-2, 5-
diphenyl-tetrazolium bromide) colorimetric assay [35].
For this purpose, MCF-7, PC3, HeLa cells were separ-
ately cultured in Dulbecco’s Modified Eagle Medium
(Sigma Aldrich, Germany), supplemented with 5% of
fetal bovine serum (FBS) (Sigma Aldrich, Germany),
100 IU/ml of Penicillin and 100 μg/ml of Strepto-
mycin in 75 cm2 flasks and kept in 5% CO2 incubator
at 37 °C. Exponentially growing cells were harvested,
counted with hemocytometer and diluted with a
particular medium. Cell culture with the concentra-
tion of 1x105 cells/ml was prepared and introduced
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(100 μL/well) into 96-well plates. After overnight
incubation, medium was removed and 200 μL of fresh
medium was added with different concentrations of
plant extracts. The stock solution of the extract was
first prepared (50 μg/ml) in DMSO and was serially
diluted up to the concentration of 0.78125 μg/ml.
After 48 h, 200 μL MTT (0.5 mg/ml) was added to
each well and incubated further for 4 h. Subsequently,
100 μL of DMSO was added to each well. The extent
of MTT reduction to formazan within cells was calculated
by measuring the absorbance at 570 nm, using a micro
plate reader (Spectra Max plus, Molecular Devices, CA,
USA). The cytotoxicity was recorded as concentration
causing 50% growth inhibition (IC50) for the cell lines
used. The percent inhibition was calculated by using the
following formula: % Inhibition = 100-[(mean of O.D of
test compound – mean of O.D of negative control)/(mean
of O.D of positive control – mean of O.D of negative
control) X 100]. The results (% Inhibition) were processed
by using Soft-Max Pro software (Molecular Device, USA).
IC50 was calculated using EZ-Fit Software.
Cell viability analysis using PI-On flow cytometry
B-lymphoma cancer cell line was a generous gift from
Switzerland, Raji (Burkitt’s lymphoma) (ATCC Catalog.
Number: CCl-86). The cell line was maintained at
37 °C in a humidified 5% CO2 environment in Roswell Park
Memorial Institute (RPMI) 1640 (Caisson, Oklahoma) with
1% L-Glutamine, 1% Penicillin/Streptomycin (Invitrogen,
Germany), supplemented with 10% fetal bovine serum
(FBS) (PAA laboratories, Austria). The cell viability analysis
using PI-On Flow cytometry was performed at Panjwani
Centre for Molecular Medicine and Drug Research, In-
ternational Centre for Chemical and Biological Sciences,
University of Karachi, Pakistan using standard protocol
[36]. Cell cytotoxicity assay was performed using florescent
dye Propidium iodide (Excitation wavelength = 536 nm)
(Emission wavelength = 617 nm). The dye has the property
that it can’t cross the intact plasma membrane and as a
result of this, live cells cannot be stained using this dye.
However, the dead cells in which cell membrane integrity is
lost, the dye penetrate inside the cell and thus intercalate
the DNA of the cell as a result of that only dead cells will
fluoresce and could be read in FL2 or FL3 channels/filters
in flow-cytometer. In order to generate dose response curve
of standard and test compounds against the cell line, cells
were seeded in round bottom 96 well plate in such a way
that each well contain 1.3x105 cells per well with 200 μl
final reaction volume. Negative control wells were given
media containing cells only while in positive control wells
0.5% of the total reaction volume of DMSO was added.
Results
The yield percentage of plant extract from the cold extrac-
tion was calculated. Yield percentage was calculated by
using following formula: Yield = (Weight of the extract
obtained)/(Total weight of the sample loaded) x 100%
Yield% ¼ 12:07
100
 100% ¼ 12:07%
In the phytochemical screening, as shown in Table 1,
we observed the presence of different phytochemicals
like steroids, terpenoids, flavonoids, reducing sugars and
glycosides. Anti-microbial assay was performed with the
plant extract of Allium wallichii by agar plate diffusion
method. Five different antibiotics were used as standard
drugs. Eight different microorganism B. cereus, B. thur-
ingiensis, E.coli, P. aeruginosa, P. mirabilis, Rhizopus, A.
flavus and B. subtilis were used for the assay.
The anti-microbial activity was assayed by measuring
the Zone of inhibition (ZOI) of different extracts on the
agar disc plate. The anti-microbial test of the Allium
wallichii was done in different concentrations of the
Table 2 Zone of Inhibition shown by standard antibiotics
Zone of Inhibition shown by standard antibiotics
B. cereus E. coli B. thuringiensis P. mirabilis Rhizopus A. flavus P. aerugenosa B. subtilis
CTX30 20 25 9 20 36 0 29 21
GEN10 27 29 30 30 27 0 15 23
CF30 34 35 35 35 30 0 40 27
C30 30 30 12 7 25 0 23 21
TE30 18 30 20 9 29 0 28 25
Fig. 1 Comparison of Percentage Scavenging of DPPH by Allium
wallichii at the concentration range (1-10 μg/ml) as compared to
Ascorbic acid
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plant used so as to study the concentration dependent
toxicity against the different bacteria and fungi. The
different concentrations used such were 200, 100, 50
and 25 mg/ml. The standard antibiotics used were
Gentamicin (GEN10), Ciprofloxacin (CF30), Chloram-
phenicol (C30), Cephotaxime (CTX30) and Tetracyc-
line (TE30) as presented in Table 2. The highest ZOI
among the five standard antibiotics used was of CTX
30 against Rhizopus as stated in the Table 2.
The plant showed concentration dependent anti-
microbial activity towards bacteria used with the highest
ZOI observed being 12 mm for B.cereus at the highest
concentration used i.e. 200 mg/ml as shown in Table 3.
The percentage scavenging activity was measured at dif-
ferent concentrations of the extracts 1 μg/ml, 2 μg/ml,
3 μg/ml, 4 μg/ml, 5 μg/ml and 10 μg/ml. The compari-
son showed that the percentage scavenging activity is
concentration dependent but the line plot of Allium
wallichii is observed below the line of Ascorbic acid,
which corresponds to the moderate activity as compared
to the standard Ascorbic acid. The percentage scaven-
ging activity of Allium wallichii (AW) was found to be
7.68, 9.79, 12.48, 14.98, 20.62 and 28.66 as compared to
8.07, 18.45, 25.81, 35.46, 44.25 and 89.25 of Standard
Ascorbic acid at concentration of 1 μg/ml, 2 μg/ml,
3 μg/ml, 4 μg/ml, 5 μg/ml 10 μg/ml respectively. The
IC50 value was calculated from the graph of regression
analysis and found to be 17.87 μg/ml as shown in Fig. 1.
Study of cytotoxicity of Allium wallichii against Prostate
Cancer (PC3) Fig. 2 and Cervical Cancer (HeLa) Fig. 3 cell
lines revealed that the plant studied was moderately cyto-
toxic to both the cancer cell lines. The cytotoxic effect of
the plant was compared with the standard (Doxorubicin).
Allium wallichii showed 59.48 ± 2.58%, 45.32 ± 1.82%, 28.53
± 2.59%, 22.58 ± 4.91% and 10.70 ± 5.66 of percent cytotox-
icity at 100 μg/ml, 50 μg/ml, 25 μg/ml, and 12.5 μg/ml and
6.25 μg/ml concentration of the extracts, respectively,
against PC3 cell lines. The IC50 value of Allium wallichii
was 69.69 μg/ml for PC3. Similarly, the percent cytotoxicity
for HeLa cell lines was 72.45 ± 2.12%, 52.61 ± 1.66%, 37.88
± 1.26%, 30.24 ± 1.33% and 16.92 ± 0.27% respectively at the
above mentioned concentration with calculated IC50 value
of 46.51 μg/ml as compared to Doxorubicin (0.85 μg/ml).
All IC50 values of the extracts were calculated using EZ-Fit
Software. From these findings, moderate cytotoxic activity of
Allium wallichii was observed towards different cancer cell
lines taken for study. We observed moderate cytotoxicity of
Allium wallichii crude extracts against Breast Cancer
(MCF-7) cell lines (Fig not shown) with the percentage in-
hibition of 45.22% at 50 μg/ml concentration with the calcu-
lated IC50 value of 55.29 μg/ml.
Table 3 Results of antimicrobial assay of Allium wallichii against different microorganisms
Plant Microbes Extract concentration (mg/ml) and Zone of inhibition (mm)
200 mg/ml 100 mg/ml 50 mg/ml 25 mg/ml
Allium wallichii B. cereus 12 11 9 9
B. thuringiensis 9 9 8 7
E. coli 7.5 7.5 6.5 6.5
P. aeruginosa 8 8 6 6
P. mirabilis 7.5 7 7 6.5
Rhizopus 7.5 7.5 7 6.5
A. flavus 9 7.5 7 6.5


















Fig. 2 Percentage Inhibition of Allium wallichi against Prostate



















Fig. 3 Percentage Inhibition of Allium wallichi against Cervical
Cancer (HeLa) cell lines. (n = 3, Values are Mean ± SD)
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Flow cytometry analysis results, as seen in Fig. 4
showed that, marker M1 is placed around the events
that are negative to florescence label, and Marker M2 is
placed to the right of M1 to designate positive events. In
our work since Propidium Iodide dye (detected at FL2
and FL3 both) is used, which holds the capability to
enter into cells with compromised cell membrane (dead
cells) consequently dead cells will take up the dye and
will show in high florescent region M2 (left part) and
viable cells will be in M1 (right half of the histogram).
The Fig. 4, shows the viability assay for the total events
gated by gate R1 of control and extracts at different con-
centrations against Burkitt’s lymphoma cell lines. As
shown in Fig. 4, for control (a) M1 corresponds to viable
75.45% and M2 correspond to dead 21.01%. For the
Allium wallichii at 0.31 mg/ml concentration (b) shows
53% viable and 46.10% dead cells. With further in-
creasing concentrations to 0.62 mg/ml (c) 85% viable
and 13.37% dead cells were observed. Similarly, at
1.23 mg/ml (d) 60.70% viable and 38.73% dead cells
(a) Control (b) 0.307 mg/ml
(c) 0.615 mg/ml (d) 1.225 mg/ml
(e) 2.425 mg/ml
Fig. 4 The Histogram plot of the viable and dead cell count from the flow cytometric analysis for Burkitt’s lymphoma cell line. Fig (a) Control,
Fig (b-e) Allium wallichi at different concentrations
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and at 2.43 mg/ml (e) 32% viable and 66.98% dead
cells were observed. Analyzing all the above data, the
IC50 value for Allium Wallichii against Lymphoma
cells used in the flow-cytometric analysis line is found
to be 3.817 ± 1.99 mg/ml which demonstrate good
cytotoxicity against Lymphoma cell lines.
Discussions
The yield percentage of 12.07%, for the plant shows that it
has various compounds in it that could have health bene-
fits. Phytochemicals like steroids, terpenoids, flavonoids
and glycosides have been shown to have anti-cancer activ-
ity. For the anti-microbial assay, the gradual decrease in
concentration showed corresponding decrease in ZOI.
The microorganism like E. coli, P. mirabilis and Rhizopus
were found to be less susceptible toward the action of Al-
lium wallichii. We can infer from the comparison be-
tween the data from Table 2 and Table 3 that, the studied
plant show only moderate antimicrobial activity. This can
be attributed to the fact that the whole plant including the
tuber of Allium wallichii along with leaves has been used
for the study; and there must be significant difference in
the phytochemicals present.
The free radical species can start chain reactions and can
cause damage or death to the cell. Antioxidants terminate
these chain reactions by removing free radical intermedi-
ates, and inhibit other oxidation reactions. Antioxidants
compounds scavenge free radicals such as peroxide, hydro-
gen peroxide or lipid peroxyl and thus inhibit the oxidative
mechanisms that lead to degenerative diseases. Screening
of plants for this is done by measuring the antioxidant ac-
tivity by various in vitro activities such as DPPH method,
Nitric Oxide method and in vivo models using rats and
mice. Free radicals that are commonly used to assess anti-
oxidant activity in vitro is 2, 2-diphenyl-1-picrylhydrazyl
(DPPH). So higher the percentage scavenging activity,
higher the antioxidant activity and higher the anticancer
property it may possess. The results in Fig. 1 show that, the
plant have moderate anti-oxidant activity.
The extract of the plant showed moderate anti-cancer ac-
tivity, when studied with cancer cell lines namely PC3,
HeLa and MCF-7. The calculated IC50 of the plant shows
that the plant can have anti-cancer activity as has been re-
ported for other plants viz. Caralluma adscendens (Roxb.),
Daedalea gibbosa, Alpinia conchigera, Chelidonium majus,
Ocimum sanctum Linn, Potentilla erecta, Chamaenerium
angustfolium, Paphia undulata, Filipendula ulmaria, Inula
helenium against different cell lines [36–42]. Analyzing the
data of FACS, the IC50 value for Allium Wallichii against
the Lymphoma cell used demonstrate good cytotoxicity.
The moderate cytotoxicity in the studies might have been
due to use of whole plant for the assay. The separation of
pure compounds with bioassay guided extraction and the
spectrometric analysis and subsequent cytotoxicity check
would reveal the bioactive components and give a better ac-
tivity. Thus, most of the research these days are directed to-
wards separation of bioactive components.
Conclusions
From the experiments performed, we concluded the
presence of different phytochemicals like steroids, terpe-
noids, flavonoids, reducing sugars and glycosides in the
plant Allium wallichii. In the DPPH-RSA assay Allium
wallichii showed moderate antioxidant activity; while
anti-microbial assay also showed moderate activity
against known pathogens. Further observations demon-
strated that the plant Allium wallichii exhibits moderate
cytotoxic activity towards Prostate cancer (PC3), cervical
cancer (HeLa) and Breast Cancer (MCF-7) cell lines.
Finally, the flow-cytometric analysis demonstrated a
good cytotoxicity of Allium wallichii against Lymphoma
cell lines with significant cell death in the population of
the Lymphoma cell line used. These results accounts for
the fact that, Allium wallichii, together with moderate anti-
oxidant and cytotoxic activity and presence of important
phytochemicals like flavonoids, steroids, glycosides and
terpenoids, can be a very important candidate to be used as
an anticancer agent. Moreover, use of plant parts separately
and the isolation of pure compounds from the plant would
certainly have better activity against cancer.
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